RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: Abzena has appointed Dr. Moncef Slaoui to its Board of Directors, bringing over 40 years of biopharmaceutical experience. Additionally, Deerfield Group is looking to expand its presence on the West Coast to support the biotech and pharmaceutical industries.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
